2020
DOI: 10.5551/jat.ed135
|View full text |Cite
|
Sign up to set email alerts
|

Loss of Skeletal Muscle Mass and Poor Prognosis in Patients with ST-Segment Elevation Myocardial Infarction: Underling Mechanisms and Therapeutic Strategies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 17 publications
0
2
0
Order By: Relevance
“…Sarcopenia is a progressive and generalized skeletal muscle disorder involving the accelerated loss of muscle mass and function that is associated with increased adverse outcomes including falls, functional decline, frailty, and mortality [31]. Several reports have shown that sarcopenia has a poor prognosis in cases of cardiovascular diseases such as heart failure and AMI [32][33][34]. Kanda et al reported that AMI patients with malnutrition on admission are more likely to progress to sarcopenia [35].…”
Section: Discussionmentioning
confidence: 99%
“…Sarcopenia is a progressive and generalized skeletal muscle disorder involving the accelerated loss of muscle mass and function that is associated with increased adverse outcomes including falls, functional decline, frailty, and mortality [31]. Several reports have shown that sarcopenia has a poor prognosis in cases of cardiovascular diseases such as heart failure and AMI [32][33][34]. Kanda et al reported that AMI patients with malnutrition on admission are more likely to progress to sarcopenia [35].…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, the presence of sarcopenia is also associated with cardiorespiratory diseases and adversely affects the cardiovascular system, causing endothelial and vascular dysfunction. Erkan et al found that sarcopenia was an independent risk factor for higher major adverse cardiovascular events in elderly patients with NSTEMI, and other studies also showed poor outcomes in this patient profile [56][57][58]. Moreover, a relationship between poor handgrip strength, slowing walking pace, and CAD has been observed [59,60].…”
Section: Sarcopeniamentioning
confidence: 97%